HJ Research delivers in-depth insights on the global Onychomycosis market in its upcoming report titled, Global Onychomycosis Market Report 2018-2029. According to this study, the global Onychomycosis market is estimated to be valued at XX Million US$ in 2023 and is projected to reach XX Million US$ by 2029, expanding at a CAGR of XX% during the forecast period. The report on Onychomycosis market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc.
This report studies the Onychomycosis market status and outlook of global and major regions, from angles of players, countries, product types and end industries, this report analyzes the top players in global Onychomycosis industry, and splits by product type and applications/end industries. This report also includes the impact of COVID-19 on the Onychomycosis industry.
Global Onychomycosis market: competitive landscape analysis
This report contains the major manufacturers analysis of the global Onychomycosis industry. By understanding the operations of these manufacturers (revenue and gross margin from 2018 to 2023), the reader can understand the strategies and collaborations that the manufacturers are focusing on combat competition in the market.
Global Onychomycosis market: types and end industries analysis
The research report includes specific segments such as end industries and product types of Onychomycosis. The report provides market size for each type and end industry from 2018 to 2023. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Onychomycosis market: regional analysis
Geographically, this report is segmented into several key countries, with market size, growth rate of Onychomycosis in these countries from 2018 to 2023, which covering United States, Canada, Germany, France, UK, Italy, Russia, Spain, Netherlands, China, Japan, Korea, India, Australia, Indonesia, Vietnam, Turkey, Saudi Arabia, South Africa, Egypt, Brazil, Mexico, Argentina, Colombia.
Key players in global Onychomycosis market include:
Abbott Laboratories
Glaxosmithkline
Pfizer
Valeant Pharmaceuticals
Galderma
Janssen Biotech
Bristol Meyer Squibb
Topica Pharmaceuticals
Sanofi
Novartis
Market segmentation, by product types:
Distal Subungual Onychomycosis
White Superficial Onychomycosis
Proximal Subungual Onychomycosis
Candida Onychomycosis
Market segmentation, by applications:
Children
Male Adults
Female Adults
Senior Citizens
1 Industry Overview of Onychomycosis
1.1 Research Scope
1.2 Market Segmentation by Types of Onychomycosis
1.3 Market Segmentation by End Users of Onychomycosis
1.4 Market Dynamics Analysis of Onychomycosis
1.4.1 Market Drivers
1.4.2 Market Challenges
1.4.3 Market Opportunities
1.4.4 Porter’s Five Forces
2 Major Manufacturers Analysis of Onychomycosis Industry
2.1 Abbott Laboratories
2.1.1 Company Overview
2.1.2 Main Products and Specifications
2.1.3 Onychomycosis Revenue and Gross Margin (2018-2023)
2.1.4 Contact Information
2.2 Glaxosmithkline
2.2.1 Company Overview
2.2.2 Main Products and Specifications
2.2.3 Onychomycosis Revenue and Gross Margin (2018-2023)
2.2.4 Contact Information
2.3 Pfizer
2.3.1 Company Overview
2.3.2 Main Products and Specifications
2.3.3 Onychomycosis Revenue and Gross Margin (2018-2023)
2.3.4 Contact Information
2.4 Valeant Pharmaceuticals
2.4.1 Company Overview
2.4.2 Main Products and Specifications
2.4.3 Onychomycosis Revenue and Gross Margin (2018-2023)
2.4.4 Contact Information
2.5 Galderma
2.5.1 Company Overview
2.5.2 Main Products and Specifications
2.5.3 Onychomycosis Revenue and Gross Margin (2018-2023)
2.5.4 Contact Information
2.6 Janssen Biotech
2.6.1 Company Overview
2.6.2 Main Products and Specifications
2.6.3 Onychomycosis Revenue and Gross Margin (2018-2023)
2.6.4 Contact Information
2.7 Bristol Meyer Squibb
2.7.1 Company Overview
2.7.2 Main Products and Specifications
2.7.3 Onychomycosis Revenue and Gross Margin (2018-2023)
2.7.4 Contact Information
2.8 Topica Pharmaceuticals
2.8.1 Company Overview
2.8.2 Main Products and Specifications
2.8.3 Onychomycosis Revenue and Gross Margin (2018-2023)
2.8.4 Contact Information
2.9 Sanofi
2.9.1 Company Overview
2.9.2 Main Products and Specifications
2.9.3 Onychomycosis Revenue and Gross Margin (2018-2023)
2.9.4 Contact Information
2.10 Novartis
2.10.1 Company Overview
2.10.2 Main Products and Specifications
2.10.3 Onychomycosis Revenue and Gross Margin (2018-2023)
2.10.4 Contact Information
3 Global Onychomycosis Market Analysis by Regions, Manufacturers, Types and End Users
3.1 Global Sales Revenue of Onychomycosis by Regions (2018-2023)
3.2 Global Sales Revenue of Onychomycosis by Manufacturers (2018-2023)
3.3 Global Sales Revenue of Onychomycosis by Types (2018-2023)
3.4 Global Sales Revenue of Onychomycosis by End Users (2018-2023)
4 Northern America Onychomycosis Market Analysis by Countries, Types and End Users
4.1 Northern America Onychomycosis Sales Revenue Analysis by Countries (2018-2023)
4.2 Northern America Onychomycosis Sales Revenue Analysis by Types (2018-2023)
4.3 Northern America Onychomycosis Sales Revenue Analysis by End Users (2018-2023)
4.4 United States Onychomycosis Sales Revenue Analysis (2018-2023)
4.5 Canada Onychomycosis Sales Revenue Analysis (2018-2023)
5 Europe Onychomycosis Market Analysis by Countries, Types and End Users
5.1 Europe Onychomycosis Sales Revenue Analysis by Countries (2018-2023)
5.2 Europe Onychomycosis Sales Revenue Analysis by Types (2018-2023)
5.3 Europe Onychomycosis Sales Revenue Analysis by End Users (2018-2023)
5.4 Germany Onychomycosis Sales Revenue Analysis (2018-2023)
5.5 France Onychomycosis Sales Revenue Analysis (2018-2023)
5.6 UK Onychomycosis Sales Revenue Analysis (2018-2023)
5.7 Italy Onychomycosis Sales Revenue Analysis (2018-2023)
5.8 Russia Onychomycosis Sales Revenue Analysis (2018-2023)
5.9 Spain Onychomycosis Sales Revenue Analysis (2018-2023)
5.10 Netherlands Onychomycosis Sales Revenue Analysis (2018-2023)
6 Asia Pacific Onychomycosis Market Analysis by Countries, Types and End Users
6.1 Asia Pacific Onychomycosis Sales Revenue Analysis by Countries (2018-2023)
6.2 Asia Pacific Onychomycosis Sales Revenue Analysis by Types (2018-2023)
6.3 Asia Pacific Onychomycosis Sales Revenue Analysis by End Users (2018-2023)
6.4 China Onychomycosis Sales Revenue Analysis (2018-2023)
6.5 Japan Onychomycosis Sales Revenue Analysis (2018-2023)
6.6 Korea Onychomycosis Sales Revenue Analysis (2018-2023)
6.7 India Onychomycosis Sales Revenue Analysis (2018-2023)
6.8 Australia Onychomycosis Sales Revenue Analysis (2018-2023)
6.9 Indonesia Onychomycosis Sales Revenue Analysis (2018-2023)
6.10 Vietnam Onychomycosis Sales Revenue Analysis (2018-2023)
7 Latin America Onychomycosis Market Analysis by Countries, Types and End Users
7.1 Latin America Onychomycosis Sales Revenue Analysis by Countries (2018-2023)
7.2 Latin America Onychomycosis Sales Revenue Analysis by Types (2018-2023)
7.3 Latin America Onychomycosis Sales Revenue Analysis by End Users (2018-2023)
7.4 Brazil Onychomycosis Sales Revenue Analysis (2018-2023)
7.5 Mexico Onychomycosis Sales Revenue Analysis (2018-2023)
7.6 Argentina Onychomycosis Sales Revenue Analysis (2018-2023)
7.7 Colombia Onychomycosis Sales Revenue Analysis (2018-2023)
8 Middle East & Africa Onychomycosis Market Analysis by Countries, Types and End Users
8.1 Middle East & Africa Onychomycosis Sales Revenue Analysis by Countries (2018-2023)
8.2 Middle East & Africa Onychomycosis Sales Revenue Analysis by Types (2018-2023)
8.3 Middle East & Africa Onychomycosis Sales Revenue Analysis by End Users (2018-2023)
8.4 Turkey Onychomycosis Sales Revenue Analysis (2018-2023)
8.5 Saudi Arabia Onychomycosis Sales Revenue Analysis (2018-2023)
8.6 South Africa Onychomycosis Sales Revenue Analysis (2018-2023)
8.7 Egypt Onychomycosis Sales Revenue Analysis (2018-2023)
9 Marketing Channel, Distributors and Traders Analysis
9.1 Marketing Channel
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Distributors and Traders
10 Global Onychomycosis Market Forecast by Regions, Countries, Manufacturers, Types and End Users
10.1 Global Sales Revenue Forecast of Onychomycosis by Regions (2024-2029)
10.2 Global Sales Revenue Forecast of Onychomycosis by Types (2024-2029)
10.3 Global Sales Revenue Forecast of Onychomycosis by End Users (2024-2029)
10.4 Global Revenue Forecast of Onychomycosis by Countries (2024-2029)
10.4.1 United States Revenue Forecast (2024-2029)
10.4.2 Canada Revenue Forecast (2024-2029)
10.4.3 Germany Revenue Forecast (2024-2029)
10.4.4 France Revenue Forecast (2024-2029)
10.4.5 UK Revenue Forecast (2024-2029)
10.4.6 Italy Revenue Forecast (2024-2029)
10.4.7 Russia Revenue Forecast (2024-2029)
10.4.8 Spain Revenue Forecast (2024-2029)
10.4.9 Netherlands Revenue Forecast (2024-2029)
10.4.10 China Revenue Forecast (2024-2029)
10.4.11 Japan Revenue Forecast (2024-2029)
10.4.12 Korea Revenue Forecast (2024-2029)
10.4.13 India Revenue Forecast (2024-2029)
10.4.14 Australia Revenue Forecast (2024-2029)
10.4.15 Indonesia Revenue Forecast (2024-2029)
10.4.16 Vietnam Revenue Forecast (2024-2029)
10.4.17 Brazil Revenue Forecast (2024-2029)
10.4.18 Mexico Revenue Forecast (2024-2029)
10.4.19 Argentina Revenue Forecast (2024-2029)
10.4.20 Colombia Revenue Forecast (2024-2029)
10.4.21 Turkey Revenue Forecast (2024-2029)
10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
10.4.23 South Africa Revenue Forecast (2024-2029)
10.4.24 Egypt Revenue Forecast (2024-2029)
11 Industry Chain Analysis of Onychomycosis
11.1 Upstream Analysis of Onychomycosis
11.2 Downstream Major Consumers Analysis of Onychomycosis
11.3 Major Suppliers of Onychomycosis with Contact Information
11.4 Supply Chain Relationship Analysis of Onychomycosis
12 Onychomycosis New Project Investment Feasibility Analysis
12.1 Onychomycosis New Project SWOT Analysis
12.2 Onychomycosis New Project Investment Feasibility Analysis
12.2.1 Project Name
12.2.2 Investment Budget
12.2.3 Project Product Solutions
12.2.4 Project Schedule
13 Onychomycosis Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.2 References and Data Sources
14.2.1 Primary Sources
14.2.2 Secondary Paid Sources
14.2.3 Secondary Public Sources
14.3 Abbreviations and Units of Measurement
14.4 Author Details
14.5 Disclaimer
Table Types of Onychomycosis
Table End Users of Onychomycosis
Figure Market Drivers Analysis of Onychomycosis
Figure Market Challenges Analysis of Onychomycosis
Figure Market Opportunities Analysis of Onychomycosis
Table Market Drivers Analysis of Onychomycosis
Table Abbott Laboratories Information List
Figure Onychomycosis Specifications of Abbott Laboratories
Table Onychomycosis Revenue (Million USD) and Gross Margin of Abbott Laboratories (2018-2023)
Figure Onychomycosis Revenue (Million USD) and Global Market Share of Abbott Laboratories (2018-2023)
Table Glaxosmithkline Information List
Figure Onychomycosis Specifications of Glaxosmithkline
Table Onychomycosis Revenue (Million USD) and Gross Margin of Glaxosmithkline (2018-2023)
Figure Onychomycosis Revenue (Million USD) and Global Market Share of Glaxosmithkline (2018-2023)
Table Pfizer Information List
Figure Onychomycosis Specifications of Pfizer
Table Onychomycosis Revenue (Million USD) and Gross Margin of Pfizer (2018-2023)
Figure Onychomycosis Revenue (Million USD) and Global Market Share of Pfizer (2018-2023)
Table Valeant Pharmaceuticals Information List
Figure Onychomycosis Specifications of Valeant Pharmaceuticals
Table Onychomycosis Revenue (Million USD) and Gross Margin of Valeant Pharmaceuticals (2018-2023)
Figure Onychomycosis Revenue (Million USD) and Global Market Share of Valeant Pharmaceuticals (2018-2023)
Table Galderma Information List
Figure Onychomycosis Specifications of Galderma
Table Onychomycosis Revenue (Million USD) and Gross Margin of Galderma (2018-2023)
Figure Onychomycosis Revenue (Million USD) and Global Market Share of Galderma (2018-2023)
Table Janssen Biotech Information List
Figure Onychomycosis Specifications of Janssen Biotech
Table Onychomycosis Revenue (Million USD) and Gross Margin of Janssen Biotech (2018-2023)
Figure Onychomycosis Revenue (Million USD) and Global Market Share of Janssen Biotech (2018-2023)
Table Bristol Meyer Squibb Information List
Figure Onychomycosis Specifications of Bristol Meyer Squibb
Table Onychomycosis Revenue (Million USD) and Gross Margin of Bristol Meyer Squibb (2018-2023)
Figure Onychomycosis Revenue (Million USD) and Global Market Share of Bristol Meyer Squibb (2018-2023)
Table Topica Pharmaceuticals Information List
Figure Onychomycosis Specifications of Topica Pharmaceuticals
Table Onychomycosis Revenue (Million USD) and Gross Margin of Topica Pharmaceuticals (2018-2023)
Figure Onychomycosis Revenue (Million USD) and Global Market Share of Topica Pharmaceuticals (2018-2023)
Table Sanofi Information List
Figure Onychomycosis Specifications of Sanofi
Table Onychomycosis Revenue (Million USD) and Gross Margin of Sanofi (2018-2023)
Figure Onychomycosis Revenue (Million USD) and Global Market Share of Sanofi (2018-2023)
Table Novartis Information List
Figure Onychomycosis Specifications of Novartis
Table Onychomycosis Revenue (Million USD) and Gross Margin of Novartis (2018-2023)
Figure Onychomycosis Revenue (Million USD) and Global Market Share of Novartis (2018-2023)
Table Global Revenue (Million USD) of Onychomycosis by Regions (2018-2023)
Table Global Revenue (Million USD) of Onychomycosis by Manufacturers (2018-2023)
Table Global Revenue (Million USD) of Onychomycosis by Types (2018-2023)
Table Global Revenue (Million USD) of Onychomycosis by End Users (2018-2023)
Table Northern America Onychomycosis Revenue (Million USD) by Countries (2018-2023)
Table Northern America Onychomycosis Revenue (Million USD) by Types (2018-2023)
Table Northern America Onychomycosis Revenue (Million USD) by End Users (2018-2023)
Figure United States Onychomycosis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Canada Onychomycosis Revenue (Million USD) and Growth Rate (2018-2023)
Table Europe Onychomycosis Revenue (Million USD) by Countries (2018-2023)
Table Europe Onychomycosis Revenue (Million USD) by Types (2018-2023)
Table Europe Onychomycosis Revenue (Million USD) by End Users (2018-2023)
Figure Germany Onychomycosis Revenue (Million USD) and Growth Rate (2018-2023)
Figure France Onychomycosis Revenue (Million USD) and Growth Rate (2018-2023)
Figure UK Onychomycosis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Italy Onychomycosis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Russia Onychomycosis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Spain Onychomycosis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Netherlands Onychomycosis Revenue (Million USD) and Growth Rate (2018-2023)
Table Asia Pacific Onychomycosis Revenue (Million USD) by Countries (2018-2023)
Table Asia Pacific Onychomycosis Revenue (Million USD) by Types (2018-2023)
Table Asia Pacific Onychomycosis Revenue (Million USD) by End Users (2018-2023)
Figure China Onychomycosis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Japan Onychomycosis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Korea Onychomycosis Revenue (Million USD) and Growth Rate (2018-2023)
Figure India Onychomycosis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Australia Onychomycosis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Indonesia Onychomycosis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Vietnam Onychomycosis Revenue (Million USD) and Growth Rate (2018-2023)
Table Latin America Onychomycosis Revenue (Million USD) by Countries (2018-2023)
Table Latin America Onychomycosis Revenue (Million USD) by Types (2018-2023)
Table Latin America Onychomycosis Revenue (Million USD) by End Users (2018-2023)
Figure Brazil Onychomycosis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Mexico Onychomycosis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Argentina Onychomycosis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Colombia Onychomycosis Revenue (Million USD) and Growth Rate (2018-2023)
Table Middle East & Africa Onychomycosis Revenue (Million USD) by Countries (2018-2023)
Table Middle East & Africa Onychomycosis Revenue (Million USD) by Types (2018-2023)
Table Middle East & Africa Onychomycosis Revenue (Million USD) by End Users (2018-2023)
Figure Turkey Onychomycosis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Saudi Arabia Onychomycosis Revenue (Million USD) and Growth Rate (2018-2023)
Figure South Africa Onychomycosis Revenue (Million USD) and Growth Rate (2018-2023)
Figure Egypt Onychomycosis Revenue (Million USD) and Growth Rate (2018-2023)
Table Global Revenue (Million USD) Forecast of Onychomycosis by Regions (2024-2029)
Table Global Revenue (Million USD) Forecast of Onychomycosis by Types (2024-2029)
Table Global Revenue (Million USD) Forecast of Onychomycosis by End Users (2024-2029)
Table Major Consumers with Contact Information of Onychomycosis
Table Major Suppliers of Onychomycosis with Contact Information
Figure Supply Chain Relationship Analysis of Onychomycosis
Table New Project SWOT Analysis of Onychomycosis
Table Project Appraisal and Financing
Table New Project Construction Period
Table New Project Investment Feasibility Analysis of Onychomycosis
Table Research Programs/Design for This Report
Table Key Data Information from Primary Sources
Table Key Data Information from Secondary Sources
Table Part of Interviewees Record List of Onychomycosis Industry
Table Part of References List of Onychomycosis Industry
Table Units of Measurement List
Table Part of Author Details List of Onychomycosis Industry
HJ Research employs comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. At HJ Research, our researchers and domain experts use a unique blend of primary and secondary research, with validation and iterations at every stage, in order to minimize deviation and present the most accurate analysis of the Onychomycosis industry. Critical elements of methodology employed for all our studies include:
Secondary Sources:
The research team first works with national bureau of statistics, national customs, market research association, state information center, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Secondary sources are mainly from press releases, company reports and publications, non-profit organizations, industry associations, government publications, economic and demographic data and customs data. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Primary Research:
In the primary research process, for comprehensive understanding of the Onychomycosis market, it is essential to understand the complete value chain and in order to facilitate this, we collect data from Onychomycosis manufacturers, Onychomycosis raw material suppliers, Onychomycosis distributors as well as buyers. The primary sources from the supply side include Onychomycosis manufacturers, opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the Onychomycosis raw materials suppliers and producers, etc. The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users, and related key executives from various key companies and organizations operating in the global market.
Technical issues and trends are obtained from surveys, technical symposia and trade journals. Technical data is also gathered from intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered.
Statistical Model and Data Analysis:
Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, and industry experience and domain expertise. Qualitative analysis includes: Onychomycosis industry landscape and trends, Onychomycosis market dynamics and key issues, Onychomycosis technology landscape, market opportunities, porter’s analysis and PESTEL analysis, Onychomycosis competitive landscape and component benchmarking, policy and regulatory scenario. Quantitative analysis includes: Onychomycosis market size and forecast by regions, Onychomycosis market size and forecast by application, Onychomycosis market size and forecast by types, Onychomycosis company market share etc.
Quality Control:
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the HJ Research’s internal quality process.
